Regulations governing visa policies and other immigration matters fall under a “foreign affairs” exception to the ...

The comment period on the proposed FAR Controlled Unclassified Information (CUI) Rule closes Mon7, 2025.  To date, filed ...

On March 3, 2025, the United States Department of Health and Human Services (“HHS”) issued a policy statement rescinding ...

Commission staff makes the new permit hearing deadline June 30 to give staff and UC San Diego more time to discuss the ...

Europe’s drug regulatory agency has given Kizfizo a negative opinion for the second time, following one from November 2024.

U.S. President Donald Trump has issued a memorandum directing federal agencies to restrict inbound and outbound investments ...

The North Chicago, Ill., biopharmaceutical company said the European Commission, which generally follows the CHMP's advice, is expected to make a final decision in the first half of the year.

The CHMP’s positive opinion includes support for administration of VYJUVEK in either a health care setting (e.g., a clinic) or at home. If deemed appropriate by a healthcare professional, trained ...

“Building on our longstanding expertise in nephrology and recent advancements in kidney diseases, this positive CHMP opinion marks an important step forward for our exciting multi-asset kidney ...

The European Commission (EC) will now review the CHMP recommendation, and a decision on the label extension application of IXCHIQ ® in the European Union (EU), Norway, Liechtenstein and Iceland ...

The European Commission (EC) will now review the CHMP recommendation, and a decision on the label extension application of IXCHIQ ® in the European Union (EU), Norway, Liechtenstein and Iceland is ...

The commission last month asked the CHMP to consider whether the new information would require an update of the positive opinion, and to consider whether the wording of the risk minimization ...